AVNS HealthcareBeta data

Avanos Medical Inc

$24.99Unavailable

Price as of the latest close · Financials updated Sep 26, 2026

Basics

Sector: Healthcare
Industry: Medical Devices
Market cap: 1.2B USD

Overall health

Not enough data: too little is reported yet for an overall view

Only 2 of 4 categories have enough reported data; an overall score needs at least 3.

See how it ranks against its peers

Worth knowing

Valuation signals disagree. Cheaper than 50% of peers on free cash flow, but only 0% on earnings.
Relative to its free cash flow, Avanos Medical looks cheaper than 50% of peers; relative to its earnings, cheaper than only 0%. The valuation score blends the two, so look at which measure fits this business best.
Not profitable yet. Reported a loss over the last 12 months.
Avanos Medical reported a net loss over the last twelve months, so earnings-based measures can't show it as cheap.
More volatile share price. Beta 1.57: tends to move more than the market.
Avanos Medical's shares have swung more with the market than most peers' (beta 1.57, above the market's 1.0).

StockQuotient Score

—Fundamentals: Yahoo Finance, not primary filings

Valuation

Is the price right?

33/100

Weak

2/3 inputs reported · Partial data

Why

Weaker than most peers on:

▼ Earnings yield

Compare with peers

Behind the score

Sector-normalized EBITDA, earnings, and free cash flow yields.

Earnings yield-6.4%

Yahoo Finance · trailing 12 monthsNegative (a loss or cash outflow), so it counts as zero whatever the share price30% base weight · Z-score -1.00Sector median: 0.0148 · MAD: 0.0148

EBITDA yieldUnavailable

Missing · left out of the score · no sector data, so not countedNot counted · remaining weights rescaledSector median: 0.0401 · MAD: 0.0401

Free cash flow yield0.6%

Yahoo Finance · trailing 12 months · operating cash flow − capital spendingReported value20% base weight · Z-score 0.00Sector median: 0.0000 · MAD: 0.0000

Other data (not scored)

Book yield67.1%

Yahoo FinanceReported valueInformational · 0% composite weightSector median: 0.3716 · MAD: 0.2313

Growth

Is it growing?

Insufficient data

Insufficient data: 0 of 3 inputs reported (at least 2 needed). We leave it blank rather than fill the gap with a made-up middle value.

Profitability

Does it earn well?

Insufficient data

Insufficient data: 0 of 3 inputs reported (at least 2 needed). We leave it blank rather than fill the gap with a made-up middle value.

Risk

Debt, liquidity, price swings

Higher

Higher relative risk

3/3 inputs reported · High confidence

Why

Weaker than most peers on:

▼ Beta

Compare with peers

Behind the score

Relative to sector peers: 0 = lower relative risk · 1 = moderate · 2 = higher. Based on leverage, beta and liquidity.

Beta1.57

Yahoo Finance · 5-year monthly beta vs the marketReported value33% base weight · Z-score -2.79Sector median: 0.6250 · MAD: 0.3380

Current ratio2.48×

Yahoo FinanceReported value33% base weight · Z-score -0.08Sector median: 2.5860 · MAD: 1.3850

Debt / equity0.18×

Yahoo FinanceReported value33% base weight · Z-score 0.22Sector median: 0.2215 · MAD: 0.2039

Valuation, growth and profitability scores: higher is better. Risk: 0 is lower, 2 is higher. Risk is a relative proxy, not a bankruptcy probability. Scores depend on available sector peers.

Questions investors ask about Avanos Medical

Is Avanos Medical getting weaker?: Filing-by-filing changes are tracked only for companies that file with the US SEC.
How is Avanos Medical valued vs its peers?: Priced higher than most peers relative to what it earns. Valuation scores 33/100 against 1,393 healthcare peers. Earnings yield -6.4% vs a peer median of 1.5% (weaker than 100% of peers).Earnings yield -6.4% vs peers 1.5% (weaker than 100% of peers).
Is Avanos Medical growing?: Insufficient data: 0 of 3 inputs reported (at least 2 needed).
How profitable is Avanos Medical?: Insufficient data: 0 of 3 inputs reported (at least 2 needed).
How risky is Avanos Medical?: Higher risk relative to 1,393 healthcare peers, judged on debt, liquidity and share-price swings. Beta 1.57 vs a peer median of 0.63 (weaker than 88% of peers).Beta 1.57 vs peers 0.63 (weaker than 88% of peers). A relative measure, not a bankruptcy probability.

Industry valuation context

Industry: Medical Devices · 33 companies

Valuations in Medical Devices are near the bottom of their range since 2016.

7% of months since 2016 were valued lower than now.
4% of companies are in the most expensive fifth of their own price-to-sales history.
Over 24 months, company values −8% and earnings +33% (medians): earnings grew faster than prices.
Median price-to-sales is +20% vs the whole market, against a usual +109%.

2016Shaded: most expensive fifth of its range2026

Financials

Detailed annual statements come from structured SEC filing data, which most US companies and some foreign filers provide. They aren’t available for this company yet.

AVNS price history

Price history is added with the daily price update and will appear after the next one.

Similar companies

Sector leaderboards

BB Biotech AGBBZA.DE100/ 100

Arbutus Biopharma CorporationABUS97/ 100

Q32 Bio Inc.QTTB97/ 100

Bringing the fundamentals into focus…

Worth knowing

Valuation signals disagree. Cheaper than 50% of peers on free cash flow, but only 0% on earnings.

Relative to its free cash flow, Avanos Medical looks cheaper than 50% of peers; relative to its earnings, cheaper than only 0%. The valuation score blends the two, so look at which measure fits this business best.

Not profitable yet. Reported a loss over the last 12 months.

Avanos Medical reported a net loss over the last twelve months, so earnings-based measures can't show it as cheap.

More volatile share price. Beta 1.57: tends to move more than the market.

Avanos Medical's shares have swung more with the market than most peers' (beta 1.57, above the market's 1.0).

Questions investors ask about Avanos Medical

Is Avanos Medical getting weaker?

Filing-by-filing changes are tracked only for companies that file with the US SEC.

How is Avanos Medical valued vs its peers?

Priced higher than most peers relative to what it earns. Valuation scores 33/100 against 1,393 healthcare peers. Earnings yield -6.4% vs a peer median of 1.5% (weaker than 100% of peers).Earnings yield -6.4% vs peers 1.5% (weaker than 100% of peers).

Is Avanos Medical growing?

Insufficient data: 0 of 3 inputs reported (at least 2 needed).

How profitable is Avanos Medical?

Insufficient data: 0 of 3 inputs reported (at least 2 needed).

How risky is Avanos Medical?

Higher risk relative to 1,393 healthcare peers, judged on debt, liquidity and share-price swings. Beta 1.57 vs a peer median of 0.63 (weaker than 88% of peers).Beta 1.57 vs peers 0.63 (weaker than 88% of peers). A relative measure, not a bankruptcy probability.